However, we detected a high SOX2 protein expression in 14% of non-amplified carcinomas suggesting that in these cases the aberrant protein expression is driven by mechanisms other than gene amplification, as also previously reported by us in breast and ovarian cancers [11]. Here, SOX2 is linked to ovarian cancer.